Common Contracts
24 similar License Agreement contracts
License AgreementLicense Agreement • January 12th, 2022 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202, Switzerland (“MPP”), and Beximco Pharmaceuticals Ltd., a company registered under the laws of Bangladesh, and having as principal place of business at 19 Dhanmondi R/A, Road No. 7, Dhaka-1205, Bangladesh (“Licensee”). Each of MPP and Licensee is referred to in this Agreement as a Party and collectively referred to in this Agreement as the Parties.
LICENSE AGREEMENTLicense Agreement • January 10th, 2022 • New York
This LICENSE AGREEMENT (the “Agreement”) is made as of 10/01/2022 (the “Effective Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202, Switzerland (“MPP”), and PT Kimia Farma Tbk a company registered under the laws of Indonesia , and having as principal place of business at Jl. Veteran No.9, Jakarta Pusat, Indonesia, 10110 (“Licensee”). Each of MPP and Licensee is referred to in this Agreement as a Party and collectively referred to in this Agreement as the Parties.
LICENSE AGREEMENTLicense Agreement • January 6th, 2022 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202, Switzerland (“MPP”), and OPTIMUS PHARMA PRIVATE LIMITED, a company registered under the laws of India, and having as principal place of business at registered corporate office at Sy. No 37A & 37P, Plot No. 6P, Signature Towers, 2nd Floor, Kothaguda, Kondapur, Hyderabad 500084.Telangana, India. (“Licensee”). Each of MPP and Licensee is referred to in this Agreement as a Party and collectively referred to in this Agreement as the Parties.
LICENSE AGREEMENTLicense Agreement • January 6th, 2022 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
License AgreementLicense Agreement • January 6th, 2022 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202, Switzerland (“MPP”), and Shanghai Desano Bio-Pharmaceutical Co., Ltd. a company registered under the laws of China , and having as principal place of business at 1479 Zhangheng Road, China (Shanghai) Pilot Free Trade Zone, Shanghai 201203, China. (“Licensee”). Each of MPP and Licensee is referred to in this Agreement as a Party and collectively referred to in this Agreement as the Parties.
LICENSE AGREEMENTLicense Agreement • January 3rd, 2022 • New York
This LICENSE AGREEMENT (the “Agreement”) is made as of 1/5/2022 (the “Effective Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
LICENSE AGREEMENTLicense Agreement • December 22nd, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202, Switzerland (“MPP”), and Aspen SA Operations (Pty) Ltd, a company registered under the laws of the Republic of South Africa, and having as principal place of business at 7 Fairclough Road, Korsten, 6020, Gqeberha, Eastern Cape, Republic of South Africa (“Licensee”). Each of MPP and Licensee is referred to in this Agreement as a Party and collectively referred to in this Agreement as the Parties.
LICENSE AGREEMENTLicense Agreement • December 21st, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202, Switzerland (“MPP”), and Incepta Pharmaceuticals Ltd., a company registered under the laws of Bangladesh, and having as principal place of business at 40, Shahid Tajuddin Ahmed Sarani, Tejgaon I/A, Dhaka 1208, Bangladesh (“Licensee”). Each of MPP and Licensee is referred to in this Agreement as a Party and collectively referred to in this Agreement as the Parties.
LICENSE AGREEMENTLicense Agreement • December 21st, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
LICENSE AGREEMENTLicense Agreement • November 19th, 2021 • New York
MERCK SHARP & DOHME CORP., a New Jersey corporation having its primary address at 2000 Galloping Hill Road, Kenilworth, New Jersey, 07033, United States, and its registered office at 820 Bear Tavern Road, West Trenton, New Jersey, 08628, United States (“MSD”);
LICENSE AGREEMENTLicense Agreement • October 26th, 2021 • New York
This LICENSE AGREEMENT (the “Agreement”) is made as of (the “Effective Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
LICENSE AGREEMENTLicense Agreement • October 26th, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
License AgreementLicense Agreement • October 26th, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
LICENSE AGREEMENTLicense Agreement • October 26th, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
LICENSE AGREEMENTLicense Agreement • October 26th, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
License AgreementLicense Agreement • October 26th, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
LICENSE AGREEMENTLicense Agreement • October 26th, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202, Switzerland (“MPP”), and Strides Pharma Science Limited a company registered under the laws of India, and having as principal place of business at Strides House, Bilekahalli, Bangalore (“Licensee”). Each of MPP and Licensee is referred to in this Agreement as a Party and collectively referred to in this Agreement as the Parties.
LICENSE AGREEMENTLicense Agreement • October 26th, 2021 • New York
WHEREAS, in accordance with MSD-MPP Agreement (as hereinafter defined), MPP has been granted by MERCK SHARP & DOHME CORP, a New Jersey corporation, USA (“MSD”) the right to sublicense certain Patents (as hereinafter defined), and MSD Know-How regarding the Substance (as hereinafter defined) used in Product (as hereinafter defined) in furtherance of its policy of improving access to COVID-19 medicines in the countries set forth in Appendix 1 hereto;
License AgreementLicense Agreement • October 26th, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
LICENSE AGREEMENTLicense Agreement • October 26th, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
LICENSE AGREEMENTLicense Agreement • October 26th, 2021 • New York
MERCK SHARP & DOHME CORP., a New Jersey corporation having its primary address at 2000 Galloping Hill Road, Kenilworth, New Jersey, 07033, United States, and its registered office at 820 Bear Tavern Road, West Trenton, New Jersey, 08628, United States (“MSD”);
LICENSE AGREEMENTLicense Agreement • October 26th, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
License AgreementLicense Agreement • October 26th, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
License AgreementLicense Agreement • October 26th, 2021 • New York
Date”) by and among the Medicines Patent Pool, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at rue de Varembé 7, Geneva 1202,
